
The Lancet Child & Adolescent Health: Monoclonal antibody nirsevimab provides strong real-world protection against ...
The Lancet Child & Adolescent Health: Monoclonal antibody nirsevimab provides strong real-world protection against severe RSV in infants, suggests meta-analysis Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at …